Figure 2From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]VAS for pain in both groups at start (T0), three weeks (T1), five weeks (T2), and eight weeks (T3) after randomization. T0-1 is the first treatment period, and T2-3 the secondBack to article page